ViCentra raised €72m in Series D funding led by Innovation Industries, w/ Partners in Equity, Invest-NL, and EQT Life Sciences and Health Innovations.
29 August 2025
29 August 2025
Total investments received (USD): 168.76M
Round value (USD): 83.88M
Company: ViCentra
Industry: Health servicesPharma
Related deals
Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden.
Investments
02 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
Investments
01 October 2025
MRM Health in a €55 million Series B financing round led by Biocodex, joined by Athos, BNP Paribas Fortis Private Equity, SFPIM, AvH, OMX, Qbic, VIB
Investments
01 September 2025
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds
Investments
01 September 2025
Hyet Solaris in a €60 million growth capital deal with Aequitas Carbon and Abbeydale Partners.
Secondary
01 September 2025
Austria
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Ireland
Italy
Portugal